Tazemetostat hydrobromide
Tazemetostat hydrobromide | |
---|---|
Term | Tazemetostat hydrobromide |
Short definition | Tazemetostat hydrobromide - (pronounced) (TA-zeh-MEH-toh-stat HY-droh-BROH-mide) drug used to treat adults and children 16 years and older with a rare type of soft tissue sarcoma called epitheloid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Tazemetostat hydrobromide - (pronounced) (TA-zeh-MEH-toh-stat HY-droh-BROH-mide) drug used to treat adults and children 16 years and older with a rare type of soft tissue sarcoma called epitheloid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. Tazemetostat hydrobromide blocks certain enzymes involved in gene expression and cell division. Blocking these enzymes can help prevent cancer cells from growing. Tazemetostat hydrobromide is a type of histone methyltransferase inhibitor. Also called Tazverik
External links
- Medical encyclopedia article on Tazemetostat hydrobromide
- Wikipedia's article - Tazemetostat hydrobromide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski